SUMMARY A change in vascular reactivity was characterized in the pig during the development of deoxycorticosterone acetate (DOCA) hypertension. Pigs, 8-12 weeks of age, were subjected to unilateral nephrectomy and instrumented with an electromagnetic flowprobe on the ascending aorta and with Tygon catheters in the aorta and thoracic vena cava. Approximately 2 weeks after surgery, Silastic strips impregnated with DOCA (100 mg/kg) were implanted subcutaneously. Within the first 3 days after implantation, mean arterial pressure (MAP) began to rise and reached levels approximately 40% greater than control during the 4th week. Graded intravenous infusions of norepinephrine or angiotensin II were given to unanesthetized pigs before, and at intervals during, the development of hypertension. Changes in total peripheral resistance were calculated from recordings of MAP and cardiac output. Comparison of pre-DOCA response curves with those obtained at intervals following DOCA implantation demonstrated a significant increase in vascular smooth muscle sensitivity (decrease in threshold infusion rates) to both drugs post-DOCA. There also was a shift to the left in the dose-response curves. These changes in systemic vascular reactivity occurred at the time the arterial pressure began to rise. The temporal relationship suggests that the increase in vascular reactivity may initiate the increase in mean arterial pressure.
VASCULAR reactivity, evaluated as the magnitude of an increase in flow resistance produced by a vasoconstrictor stimulus, is enhanced in chronic hypertension in man 12 and animals. 3 ' 4 There is little agreement as to the nature of the changes in the blood vessel responsible for this increase in reactivity. Furthermore, it is not certain whether the change in vascular reactivity is the cause or the consequence of hypertension. In the current study, the temporal relationship between the development of hypertension and the increase in vascular reactivity was studied in the DOCA hypertensive pig. Whole body vascular reactivity was evaluated to give information about the net change in all vascular beds. This is the first study in which the time course of changes in whole body vascular reactivity have been monitored in a single animal as it develops hypertension. The study permits inferences about the cause and effect relationship between vascular reactivity and hypertension.
Methods

Surgical Preparation
All studies were carried out on young male feeder pigs (Chester White or Yorkshire boars) housed in individual cages and given Purina Pig Chow and tap water ad libitum. Two surgical procedures were required for chronic instrumentation of the pigs. 5 The first consisted of implantation of an electromagnetic flowprobe (Zepeda Instruments) around the ascending aorta to monitor cardiac output and insertion of a Herd-Barger Tygon catheter into the aorta just distal to the probe to measure arterial pressure. The following procedures were performed approximately 1 week later: right nephrectomy, complete ligation of the left external iliac artery, and implantation of catheters into the vena cava (advanced from the abdominal region to the central venous pool) and left femoral artery. All catheters and electrodes were exteriorized, tied to a heavy wire loop implanted on the pig's left side, and protected with a heavy canvas jacket. Approximately 2 weeks after the second surgery, animals received subcutaneous implants of Silastic strips (silicone rubber, Dow Corning) impregnated with dexycorticosterone acetate, 100 mg/kg (DOCA, Sigma Chemical Co.). Control pigs received Silastic implants without DOCA. Cardiac output and pressures were monitored daily. Pigs were maintained on conventional pig chow and tap water. This diet provided a sodium intake of approximately 3-5 mEq/kg per day.
Experimental Protocol: Infusion Studies
Prior to and at intervals after the implantation of DOCA, the pigs were subjected to graded intravenous infusions of norepinephrine (NE) (Levophed Bitartrate, Winthrop Laboratories) and angiotensin II (A II) (Hypertensin, Ciba Laboratories). All studies were performed on unanesthetized pigs restrained on their right side. The study room was kept as quiet as possible and lights were dimmed. The pigs tolerated the procedure well and would usually doze during the 60-to 90-minute procedure.
Infusion rates of both drugs were varied from subthreshold rates to those producing an increase of 50-70 mm Hg in mean arterial pressure (MAP). Infusions were carried out with a Harvard infusion pump (model 975); drug doses were varied by changing the rate of infusion.
During the experiments the following parameters were monitored: (1) MAP, (2) cardiac output (CO), and (3) heart rate. Total peripheral resistance (TPR) was calculated as the quotient of MAP divided by CO. In the figures to follow, CO and therefore TPR are expressed in arbitrary units (mm pen deflection/kg for CO and mm Hg/ mm pen deflection per kg x 10' 2 for TPR) because the flowprobe had not been calibrated. Subsequent in vitro flowprobe calibration indicated that a deflection of 1.0 mm represented flows ranging from 0.25 to 0.35 liter/ min.
Each dose of NE and A II tested was infused for 3 minutes. The resposne to each dose was found to reach a plateau within 2.5 minutes. The infusion was then followed by a rest period adequate to allow parameters to return to baseline (3-5 minutes) before the next dose was tested. An average of 12 infusions was administered in one session. Different infusion rates were randomly sequenced and each rate was repeated twice. In order to prevent any interaction between the drugs, infusions of NE and A II were not given on the same day. If the pig became uncomfortable or agitated during the study, the experiment was terminated and the data discarded.
Statistical Methods
Results are presented as the mean of the hemodynamic response ± the standard error (SE) at specific times following the intervention with DOCA or Silastic (control) implantation. Differences in responses to a given dose of the drug administered before, and at a specific time interval after the implantation, were tested by a paired tstatistical analysis.
Results
Development of Hypertension
All pigs implanted with DOCA demonstrated elevations in MAP within the first 3 days. By the end of the 1st week, MAP was approximately 20% greater than the pre-DOCA level (Table 1 ) and, during the 4th post-DOCA week, the MAP had plateaued at approximately 36% above the pre-DOCA values.
Infusion Studies
Systemic Response to NE in Control Pigs
Intravenous infusion of NE in unanesthetized normotensive pigs produced the following hemodynamic changes: (1) a rise in MAP, (2) an increase in TPR, (3) a decrease in heart rate, and (4) a decrease in CO. The rise in MAP in response to NE is therefore due to widespread vasoconstriction as evidenced by the increase in calculated TPR. The average threshold infusion rate of NE required to produce an elevation in MAP in five out of five control pigs tested was: 0.122 fxg/kg per min. The mean rise in MAP at this rate was 7.0 ± 1.3 mm Hg. Two out of five pigs responded to a rate of 0.073 /Mg/kg per min, the mean rise in MAP for those responding being 4.8 ± 0.88 mm Hg. The average threshold infusion rate was therefore considered to be between 0.073 and 0.122 /xg/kg per min.
Comparisons of MAP, TPR, and CO changes in control pigs (n = 5) at various time intervals during their experimental life (i.e., before Silastic implantation and 2 weeks and 1 month after) demonstrate that there was not much variability in dose-response curves over time. Furthermore, the threshold infusion rate of NE required to produce a response remained constant during this period (Fig-!) •
Systemic Response to NE in DOCA Hypertensive Pigs
In contrast to the control animals, the DOCA hypertensive pigs demonstrated changes in systemic cardiovascular responses to NE infusions. The changes in reactivity occurred early in the development of hypertension. Following the administration of DOCA, a given infusion rate of NE produced a greater rise in MAP and TPR than it Pressures were direct mean arterial measurements taken from the thoracic aortic catheter. Pressure data for the hypertensive pigs are expressed as the actual group measurements ± SD and the percent changes from pre-DOCA averages. For ease of display, data are aggregated into 3-day averages up to and including the 30th day post-DOCA. did during the pre-DOCA period, and the threshold infusion rate of NE was lower. Figure 2 shows the NEinduced changes in MAP, TPR, and CO at (A) 1 week (n = 8), and (B) 1 month (n = 6) after DOCA implantation compared to values obtained the same pigs during the pre-DOCA, normotensive stage. Paired r-analysis of the differences in the NE dose-response curves obtained in the pre-DOCA stage and at the two intervals after implantation of DOCA demonstrates that the magnitude of change in MAP and TPR elicited by NE is significantly greater after DOCA implantation. No significant changes were found in the decrease in CO between pre-DOCA and post-DOCA stages. An increase in systemic vascular reactivity is indicated by shifts to the left of the MAP and TPR response curves. Response curves obtained at both 1 week and 1 month after DOCA implantation demonstrated a significant decrease in the threshold infusion rate of NE required to elicit a response. In the pre-DOCA stage, the average minimal NE infusion rate at which 100% of the pigs showed a response was 0. To ascertain whether there was any difference in the dose-response curves to norepinephrine at 1 week and 1 month post-DOCA, we compared equieffective infusion rates of norepinephrine producing a 30 mm Hg rise in MAP. The mean infusion rate of norepinephrine required to produce a 30 mm Hg change in MAP decreased from 0.46 ± 0.04 (SE) /xg/kg per min pre-DOCA to 0.23 ± 0.03 /xg/kg per min 1 week post-DOCA and 0.195 ± 0.02 /xg/kg per min 1 month post-DOCA. The decrease in the infusion rate at 1 month post-DOCA was not significantly different from that obtained at 1 week post-DOCA (P > 0.10). There appears to be little further increase in systemic vascular reactivity between 1 week and 1 month following DOCA implantation.
Systemic Response to A II in Control Pigs
The pattern of hemodynamic changes elicited by intravenous infusion of A II was found to be similar to that obtained for NE. Infusion of A II produced the following circulatory changes: (1) a rise in MAP, (2) a rise in TPR, (3) a fall in heart rate, and (4) a fall in CO. Figure 3 shows a comparison of MAP, TPR, and CO changes in control pigs (rt = 5) before Silastic implantation and at 2 weeks and 1 month after Silastic implantation. Like the findings for NE, the systemic response to A II in control pigs was not subject to much variability over time. The threshold infusion rate of A II required to elicit a response in five of the five pigs was 0.023 /xg/kg per min. The average rise in MAP at this rate was 12.5 ± 0.85 mm Hg. Four out of five of the pigs responded to a rate of 0.012 /xg/kg per min; the mean rise in MAP for those responding was 5.8 ± 0,45 mm Hg. The average threshold infusion rate was, therefore, considered to be between 0.012 and 0.023 /xg/ kg per min, and this did not change with time.
Systemic Response to A II in DOCA Hypertensive Pigs
DOCA hypertensive pigs demonstrated marked changes in systemic vascular reactivity to A II. Paralleling the changes in response to NE, the onset of changes in reactivity to A II also occurred very early in the develop- Figure 4 shows the changes in MAP, TPR, and CO at (A) 1 week (w = 9) and (B) 1 month (n = 6) after DOCA implantation compared to changes in these parameters in the pre-DOCA period. Paired /-analysis demonstrated that the magnitude of change in MAP and TPR elicited by A II is significantly greater after DOCA implantation. Like the findings for NE, no significant changes were noted in the magnitude of the decrease in CO. MAP and TPR curves were shifted to the left, indicating significant increases in systemic vascular reactivity. A significant decrease in the threshold infusion rate of A II was observed both at 1 week and 1 month post-DOCA. In the pre-DOCA stage, the average A II infusion rate at which nine out of the nine pigs showed a response was 0.0285 /xg/kg per min. The mean rise in MAP was 18. In six DOCA-hypertensive pigs, systemic vascular reactivity to A II was assessed at 2 and 4 days post-DOCA implantation. Figure 5 compares the changes in MAP before and 2 and 4 days after DOCA implantation. As early as 2 days post-DOCA, a lowering of the threshold dose of A II required for response was apparent, as well as a shift to the left of the response curve. These changes in vascular reactivity were found to occur at a time when the mean arterial pressure was starting to rise. whole animal vascular resistance increase, isolated vascu r lar bed resistance increase, and isolated vascular smooth muscle contraction. Each of these responses makes its special contribution to the understanding of vascular changes in hypertension. Whole animal studies in which a vasoconstrictor is infused intravenously and simultaneous measurements are made of MAP and CO permit calculation of a change in TPR. They allow a more direct interpretation of the effect of changes in vascular reactivity on MAP than do studies on the isolated vascular bed. However, with this method, the magnitude of a constrictor response depends not only on the sensitivity of vascular smooth muscle and on the thickness of the walls of the resistance vessels, but also on all extrinsic factors (neural and humoral) which participate in the complex vascular regulation during a pressor response .
Discussion
Evaluation of Changes in Vascular Reactivity
In perfusion studies of the isolated vascular bed, extrinsic neurogenic factors can be eliminated by denervation and extrinsic humoral factors can be eliminated by perfusion wth a physiological salt solution. Unique aspects of the reactivity of specific vascular beds can be identified. Still it is difficult to differentiate functional alterations in vascular smooth muscle from structural changes in vessel wall thickness as a cause of arterial vascular reactivity.
Studies of isolated vascular smooth muscle strips are not biased by structural changes (i.e., the changes in wall thickness-lumen diameter ratio) that alter vascular reactivity in any vascular resistance study. Therefore, a more direct study of vascular smooth muscle function can be made. Specific assessment can be made of vascular smooth muscle sensitivity and its maximum force-generating ability (contractility). These studies are limited to large arteries (carotid, femoral, aorta), and it is not known how well changes in muscle from these large arteries reflect changes in the smooth muscle of resistance vessels.
The present study of whole animal reactivity in the pig is the first longitudinal study of changes in vascular reactivity in the same animal during the development of hypertension. These studies done before and after DOCA implantation permit inferences concerning the mechanisms underlying the development of changes in reactivity and the temporal relationship between changes in reactivity and the rise in MAP. Although only results at 1 week and 1 month post-DOCA are reported, studies were run at weekly intervals. The magnitude of the changes observed at 2 and 3 weeks post-DOCA did not differ from data obtained at 1 week.
General Mechanisms underlying Increased Vascular Reactivity in the Initial Stages of Hypertension
Evidence of enhanced whole body vascular reactivity in the DOCA hypertensive pig agrees with previous findings in hypertensive human subjects.
1 ' 2 The observed decrease in threshold and increase in reactivity to NE and A II are not merely reflections of the greater initial resistance after DOCA. Studies from numerous laboratories 6 "* have demonstrated that an increase in initial resistance per se tends to decrease the magnitude of a pressor response. In the DOCA hypertensive pig, vascular reactivity does not become further enhanced beyond that found at 1 week post-DOCA in spite of the continuing increase in MAP. There is much evidence that vascular reactivity may be increased merely by increasing vessel wall thickness. This structural change confers a mechanical advantage to vascular smooth muscle so that a given shortening produces a greater decrease in lumen size and therefore an enhanced constrictor response to a given concentration of a vasoconstrictor. This structural change produces an enhanced constrictor response without altering the threshold dose of the vasoconstrictor.
We have interpreted an increased vascular smooth muscle sensitivity as indicative of a functional alteration in vascular smooth muscle. We have evaluated the sensitivity of this muscle in terms of the threshold dose of a vasoconstrictor required to produce a response. The rapid development in the hypertensive pig of changes in vascular reactivity, particularly decreases in the threshold dose of NE and A II, cannot be attributed to structural changes in the blood vessels. Structural changes are secondary adap- 
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tations to the rise in arterial pressure and, therefore, have only a maintenance role in hypertension.'
Ol " In studies with renal hypertensive rats, Collis and Alps 10 observed that the appearance of structural vascular changes lagged behind the development of hypertension, whereas the rise in their index for vascular sensitivity to NE paralleled the rise in MAP. Structural changes can be prevented in vascular beds protected from a rise in arterial pressure in hypertensive animals" or, under certain circumstances, reversed by antihypertensive treatment. 12 Berecek and Bohr 13 evaluated structural vascular resistance in the hindlimbs of DOCA hypertensive pigs by measuring resistance in the maximally dilated vascular bed. They found that structural resistance was high in the hindlimbs exposed to an elevated arterial pressure, but that it was not elevated in contralateral hindlimbs protected from the rise in pressure by ligation of the external iliac artery.
Development of changes in vascular reactivity prior to the rise in arterial pressure has been seen in other animal models of hypertension and in humans. Odgen et al., 14 using renal hypertensive rabbits, found that increased vascular reactivity to pitressin occurred before the animals developed a rise in arterial pressure. McQueen 15 showed that increased reactivity to NE in the perfused tail artery of a one-kidney renal hypertensive rat was evident within 2 days after clipping the sole kidney. In two-kidney renal hypertensive rats, he found that increased reactivity to NE paralleled the rise in arterial pressure for up to 2 weeks. At this time the increase in vascular reactivity was fully established and there was no further relationship between blood pressure and vascular reactivity. This is similar to findings for the pig in which there appears to be no further increase in vascular reactivity beyond that found 1 week post-DOCA. Doyle NE into the brachial artery induced greater vasoconstriction in the forearm in normotensive offspring of hypertensive patients than in a control group with parents that had normal blood pressures. In essential hypertension as well as in numerous animal models of hypertension, it appears that a change in vascular reactivity precedes the rise in blood pressure and could therefore be an important factor in the pathogenesis of hypertension. The distinct lowering of threshold doses of both A II and NE was found to parallel the alterations in vascular reactivity in the DOCA hypertensive pig. This parallelism supports the hypothesis that alterations in vascular smooth muscle sensitivity may be the primary vascular defect occurring in the genesis of hypertension. Since there is increased sensitivity to more than one agonist, it does not appear to be a receptorspecific phenomenon. Alterations in vascular smooth muscle sensitivity may have a primary role in the rise in arterial pressure.
Possible Mechanisms underlying the Increase in Sensitivity of Vascular Smooth Muscle
Current speculations about the mechanisms underlying the increase in sensitivity of vascular smooth muscle in DOCA hypertension include the following: (1) 28 or indirect 29 myogenic effect of mineralocorticoids, and (5) altered neurogenic influence producing chronic functional alteration in vascular smooth muscle. 30 The mechanism of altered neurogenic influence recently has received much attention and merits further consideration. Haeusler et al. 31 demonstrated that intracerebroventricular injection of 6-hydroxydopamine prior to carrying out procedures which normally induced one-kidney and DOCA hypertension or prior to the development of spontaneous hypertension in the SHR strain, prevented the development of hypertension in these animals. The same drug was found to be ineffective in altering blood pressure when administered during the phase of established hypertension. 31 These findings have been confirmed in other laboratories 30 - 32 and strongly suggest that there is a centrally located neural "trigger" mechanism that initiates these types of hypertension. It is tempting to speculate that there occurs in hypertension an alteration in peripheral sympathetic activity set in motion by a central "trigger" mechanism and that this alteration in neural input causes an intrinsic change in the sensitivity of vascular smooth muscle. Comparatively few studies have been made of the trophic interactions between vascular smooth muscle and its innervation, particularly in the adult animal. Bevan 33 has given in vivo evidence that adrenergic neurons exert a trophic influence on vascular structure and function during growth. There also is evidence that nerve-dependent changes in the sensitivity of vascular smooth muscle are consistent with those seen in other excitable tissue. 34 Nerve-induced alterations in vascular smooth muscle sensitivity do not appear to be due to changes in specific receptors, but involve alterations in membrane electrical properties, binding of and permeability to ions, and possibly other biochemical changes. 35 It may be hypothesized that an initial alteration in neural input to vascular smooth muscle produces intrinsic functional alterations in the muscle detected by other investigators, such as alterations in electrogenesis 17 and ion permeability. 20 Alteration in functional properties of vascular smooth muscle in the current study was detected as an increase in sensitivity. This alteration may underlie the initial rise in resistance and the enhanced vascular reactivity seen in hypertension.
